Arthur S. Przybyl
2019
Compensation breakdown
| Non-Equity Incentive Plan | $703,350 |
|---|---|
| Option Awards | $1,826,793 |
| Salary | $776,767 |
| Stock Awards | $2,475,019 |
| Other | $33,831 |
| Total | $5,815,760 |
Przybyl received $2.5M in stock awards, accounting for 43% of the total pay in 2019.
Przybyl also received $703.4K in non-equity incentive plan, $1.8M in option awards, $776.8K in salary and $33.8K in other compensation.
Rankings
In 2019, Arthur S. Przybyl's compensation ranked 1,791st out of 13,971 executives tracked by ExecPay. In other words, Przybyl earned more than 87.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,791 out of 13,971 | 87th |
Division Manufacturing | 641 out of 5,701 | 89th |
Major group Chemicals And Allied Products | 195 out of 2,200 | 91st |
Industry group Drugs | 156 out of 1,886 | 92nd |
Industry Pharmaceutical Preparations | 116 out of 1,398 | 92nd |
Pay ratio
| Arthur S. Przybyl's Pay | $5,815,760 |
|---|---|
| Median Employee's Pay | $46,642 |
| Pay Ratio | 125to 1 |
In 2019, the annual total compensation of Arthur S. Przybyl was $5,815,760.
The annual total compensation of the median employee at ANI Pharmaceuticals was $46,642.
The ratio of Arthur S. Przybyl's pay to the pay of median employee was therefore 125 to one.
Przybyl's colleagues
We found three more compensation records of executives who worked with Arthur S. Przybyl at ANI Pharmaceuticals in 2019.